1. Home
  2. AMPL vs EVO Comparison

AMPL vs EVO Comparison

Compare AMPL & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPL
  • EVO
  • Stock Information
  • Founded
  • AMPL 2012
  • EVO 1993
  • Country
  • AMPL United States
  • EVO Germany
  • Employees
  • AMPL N/A
  • EVO N/A
  • Industry
  • AMPL EDP Services
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMPL Technology
  • EVO Health Care
  • Exchange
  • AMPL Nasdaq
  • EVO Nasdaq
  • Market Cap
  • AMPL 1.7B
  • EVO 1.5B
  • IPO Year
  • AMPL 2021
  • EVO 2021
  • Fundamental
  • Price
  • AMPL $12.45
  • EVO $4.12
  • Analyst Decision
  • AMPL Buy
  • EVO Buy
  • Analyst Count
  • AMPL 10
  • EVO 2
  • Target Price
  • AMPL $13.40
  • EVO $5.90
  • AVG Volume (30 Days)
  • AMPL 1.2M
  • EVO 113.5K
  • Earning Date
  • AMPL 08-07-2025
  • EVO 08-13-2025
  • Dividend Yield
  • AMPL N/A
  • EVO N/A
  • EPS Growth
  • AMPL N/A
  • EVO N/A
  • EPS
  • AMPL N/A
  • EVO N/A
  • Revenue
  • AMPL $306,601,000.00
  • EVO $851,944,444.00
  • Revenue This Year
  • AMPL $12.78
  • EVO $10.08
  • Revenue Next Year
  • AMPL $10.79
  • EVO $10.99
  • P/E Ratio
  • AMPL N/A
  • EVO N/A
  • Revenue Growth
  • AMPL 8.56
  • EVO 1.50
  • 52 Week Low
  • AMPL $7.37
  • EVO $2.84
  • 52 Week High
  • AMPL $14.88
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • AMPL 51.90
  • EVO 49.74
  • Support Level
  • AMPL $11.87
  • EVO $4.12
  • Resistance Level
  • AMPL $13.33
  • EVO $4.26
  • Average True Range (ATR)
  • AMPL 0.50
  • EVO 0.11
  • MACD
  • AMPL -0.02
  • EVO -0.01
  • Stochastic Oscillator
  • AMPL 43.23
  • EVO 41.03

About AMPL Amplitude Inc.

Amplitude Inc is a Software company that provides a Digital Analytics Platform that helps companies analyze their customer behavior within digital products. The Company delivers its application over the Internet as a subscription service using a software-as-a-service (SaaS) model and also it offers customer support related to initial implementation setup, ongoing support services, and application training. The company generates revenue primarily through selling subscriptions to the platform. The company derives a majority of its revenue from the United States.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: